Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport ; volume:9 ; number:1 ; day:16 ; month:4 ; year:2019 ; pages:1-11 ; date:12.2019
Scientific reports ; 9, Heft 1 (16.4.2019), 1-11, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Horakova, Olga
Kroupova, Petra
Bardova, Kristina
Buresova, Jana
Janovska, Petra
Kopecky, Jan
Rossmeisl, Martin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-42531-0
- URN
-
urn:nbn:de:101:1-2019042820583453968194
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:47 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Horakova, Olga
- Kroupova, Petra
- Bardova, Kristina
- Buresova, Jana
- Janovska, Petra
- Kopecky, Jan
- Rossmeisl, Martin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Inhibition of upper small intestinal mTOR lowers plasma glucose levels by inhibiting glucose production
Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals
BCAAs acutely drive glucose dysregulation and insulin resistance: role of AgRP neurons
Reciprocating intestinal flows enhance glucose uptake in C. elegans
Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures
Development of metformin tablet that mimics the circadian variation of glucose levels
Cryptosporidium parvum competes with the intestinal epithelial cells for glucose and impairs systemic glucose supply in neonatal calves
![Untersuchungen zum Glucose-Auswärtstransport des Na+/Glucose-Cotransporters [Na+/Glucose-Cotransporters] SGLT1](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Untersuchungen zum Glucose-Auswärtstransport des Na+/Glucose-Cotransporters [Na+/Glucose-Cotransporters] SGLT1
Untersuchungen zum Glucose-Auswärtstransport des Na+/Glucose-Cotransporter [Na+/Glucose-Cotransporters] SGLT1
Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism
Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes
HNF4α is a novel regulator of intestinal glucose-dependent insulinotropic polypeptide
Inhibition of upper small intestinal mTOR lowers plasma glucose levels by inhibiting glucose production
Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals
BCAAs acutely drive glucose dysregulation and insulin resistance: role of AgRP neurons
Reciprocating intestinal flows enhance glucose uptake in C. elegans
Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures
Development of metformin tablet that mimics the circadian variation of glucose levels
Cryptosporidium parvum competes with the intestinal epithelial cells for glucose and impairs systemic glucose supply in neonatal calves
Untersuchungen zum Glucose-Auswärtstransport des Na+/Glucose-Cotransporters [Na+/Glucose-Cotransporters] SGLT1
Untersuchungen zum Glucose-Auswärtstransport des Na+/Glucose-Cotransporter [Na+/Glucose-Cotransporters] SGLT1
Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism
Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes
HNF4α is a novel regulator of intestinal glucose-dependent insulinotropic polypeptide
Inhibition of upper small intestinal mTOR lowers plasma glucose levels by inhibiting glucose production
Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals
BCAAs acutely drive glucose dysregulation and insulin resistance: role of AgRP neurons
Reciprocating intestinal flows enhance glucose uptake in C. elegans
Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures
Development of metformin tablet that mimics the circadian variation of glucose levels
Cryptosporidium parvum competes with the intestinal epithelial cells for glucose and impairs systemic glucose supply in neonatal calves
Untersuchungen zum Glucose-Auswärtstransport des Na+/Glucose-Cotransporters [Na+/Glucose-Cotransporters] SGLT1
Untersuchungen zum Glucose-Auswärtstransport des Na+/Glucose-Cotransporter [Na+/Glucose-Cotransporters] SGLT1
Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism
Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes